Tags: Drug.

Epelsiban (GSK-557296-B) is an oral drug which acts as a selective sub-nanomolar (Ki=0.13 nM) oxytocin receptor antagonist with >31000-fold selectivity over the related vasopressin receptors and is being developed by GlaxoSmithKline for the treatment of premature ejaculation in men.

Epelsiban.svg
ATC prefix
None
CAS number
872599-83-2
CAS supplemental
1159097-48-9 (besylate)
IUPAC name
(3R6R)-3-(23-dihydro-1H-inden-2-yl)-1-[(1R)-1-(26-dimethylpyridin-3-yl)-2-(morpholin-4-yl)-2-oxoethyl]-6-[(1S)-1-methylpropyl]piperazine-25-dione
PubChem
11634973

Loading...

This page contains content from the copyrighted Wikipedia article "Epelsiban"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.